Oncology
Oncology
Oncology
Nanoparticles Encapsulating Chemotherapy Drugs to Kill Triple Negative Breast Cancer
The cells of triple negative breast cancer tumors don't have receptors for estrogen, progesterone, and HER2, the main targets used to attack breast cancers. This is why they're so difficult to treat, but researchers at George Washington...
Oncology
Micro-Patterned Cell Culture Platform Reveals Unknown Cancer Behavior
Researchers at Hokkaido University have developed a micro-patterned cell culture platform to study the behavior of pancreatic cancer cells. The new cell culture substrate revealed previously unknown and clinically relevant pancreatic cell behaviors...
Oncology
Precipio Announces ICEme Kit for Lung Cancer Mutation Detection
Earlier this year, Medgadget heard from Precipio CEO Illan Danieli on how his company uses advanced diagnostics and personalized medicine to reduce the prevalence of cancer misdiagnosis. Over 1 million patients globally and about 200,000 patients...
Oncology
Focused Ultrasound and Intranasal Drug Delivery for Brain Cancer Therapy
Researchers at Washington University in St. Louis have developed a new method to bypass the blood-brain barrier and deliver drugs to the brain, which could be particularly useful in difficult-to-treat brain tumors. The technique involves...
Oncology
Deton is Developing “Aerosol Biopsy” to Detect Lung Diseases
Biopsies and bronchoscopies are the gold standard for diagnosing lung diseases, including pneumonia and cancer. However, these procedures are difficult to provide, requiring general anesthesia and an operating room. Deton hopes to simplify the...
Oncology
New Sniper Balloon Occlusion Microcatheters Cleared in Europe
Embolx, out of Silicon Valley, won the European CE Mark for its latest Sniper Balloon Occlusion Microcatheters. The devices are used to help deliver embolic agents in such varying procedures as helping to treat tumors, uterine fibroids,...
Oncology
Artificial Intelligence Optimizes Chemo and Radiotherapy to Treat Glioblastomas
Patients with glioblastoma, a persistent and difficult to treat brain cancer, often end up suffering through multiple rounds of chemo and radiation therapy. Scientists at MIT have been working on harnessing the power of artificial intelligence...
Oncology
Genotype-Specific Microparticle Treatment for Brain Cancer
Researchers from Harvard and MIT have developed microparticles that can treat a specific genetic subtype of glioma, a brain cancer. The microparticles slowly release a drug that specifically targets cancer cells that rely on a particular enzyme....
Oncology
New Device for Testing Immunotherapies on Tumor Fragments
Immuno-oncology, a rapidly developing field that harnesses the body's immune system to attack cancers, lacks effective methods of testing potential therapies. In addition to animal studies, tiny bits of tumors are placed, along with chemical...
Oncology
Your information will never be shared with any third party.